Posterior Reversible Encephalopathy Syndrome During Acute Lymphoblastic Leukemia Treatment
Articles > Article · 2021
Authors: Sila ATAMYILDIZ UÇAR, Eda ATASEVEN, Cenk ERASLAN, Mehmet KANTAR
The Journal of Tepecik Education and Research Hospital, Other Refereed National Journals, International, TR DİZİN (ULAKBİM), 2021, vol 31, pp 416-420
Summary
Posterior reversible encephalopathy syndrome (PRES) is a clinical and radiological syndrome, characterized by acute onset of headache, altered mental status, visual impairment, nausea, vomiting, seizure, and hypertension. PRES is a reversible condition if it is recognized early, but neurological damage or even death may occur. Herein, we present two cases of ALL who developed PRES during their induction therapy and a literature review of PRES.